Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

BUY
$4.52 - $10.57 $1,536 - $3,593
340 Added 2.22%
15,689 $166,000
Q2 2022

Aug 05, 2022

BUY
$3.65 - $7.3 $36 - $73
10 Added 0.07%
15,349 $61,000
Q4 2021

Feb 08, 2022

BUY
$5.59 - $7.39 $872 - $1,152
156 Added 1.03%
15,339 $86,000
Q2 2021

Aug 10, 2021

BUY
$6.71 - $11.04 $4,133 - $6,800
616 Added 4.23%
15,183 $128,000
Q4 2020

Feb 08, 2021

BUY
$11.79 - $18.94 $9,078 - $14,583
770 Added 5.58%
14,567 $247,000
Q3 2020

Nov 09, 2020

BUY
$10.34 - $15.2 $1,964 - $2,888
190 Added 1.4%
13,797 $177,000
Q2 2020

Aug 07, 2020

BUY
$7.81 - $17.0 $106,270 - $231,319
13,607 New
13,607 $192,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0

About Provention Bio, Inc.


  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.